Amphastar Pharmaceuticals, Inc. AMPH

Latest FY: 2025 Healthcare Drug Manufacturers - Specialty & Generic
Market Price $23.80
Market Cap $1.05B
P/E Ratio 11.72
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↓-1.7% YoY
$719.89M
3-Yr CAGR: 13.0%
Net Income ↓-38.5% YoY
$98.09M
Net Margin: 13.6%
Free Cash Flow ↓-29.7% YoY
$121.23M
FCF Yield: 11.56%
EPS (Diluted) ↓-33.7% YoY
$2.03
Basic: $2.10
Return on Equity Efficiency
22.0%
ROA: 6.0%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (AMPH)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $255.2M $104.2M $10.5M $0.22 0.00% $38.6M $17.2M
FY 2017 $240.2M -5.9% $90.8M $4.5M -57.2% $0.09 -59.1% 0.00% $39.2M $4.1M -76.1%
FY 2018 $294.7M +22.7% $107.0M $-5.7M -227.3% $-0.12 -233.3% 0.00% $38.2M $-8.6M -309.7%
FY 2019 $322.4M +9.4% $131.9M $48.9M +952.9% $0.98 +916.7% 0.00% $41.8M $0.2M +102.4%
FY 2020 $349.8M +8.5% $143.3M $1.4M -97.1% $0.03 -96.9% 0.00% $57.3M $23.4M +11,209.7%
FY 2021 $437.8M +25.1% $199.7M $62.1M +4,327.4% $1.25 +4,066.7% 0.00% $98.0M $70.5M +201.3%
FY 2022 $499.0M +14.0% $248.9M $91.4M +47.1% $1.74 +39.2% 0.00% $89.2M $65.1M -7.6%
FY 2023 $644.4M +29.1% $351.1M $137.5M +50.5% $2.60 +49.4% 0.00% $183.5M $145.3M +123.1%
FY 2024 $732.0M +13.6% $373.9M $159.5M +16.0% $3.06 +17.7% 0.00% $213.4M $172.3M +18.6%
FY 2025 $719.9M -1.7% $356.1M $98.1M -38.5% $2.03 -33.7% 0.00% $156.1M $121.2M -29.7%
$

Valuation

Market Price $23.80
Market Cap $1.05B
Enterprise Value $1.50B
P/E Ratio 11.72
P/B Ratio 2.36
FCF Yield 11.56%
Dividend Yield N/A
Shares Outstanding 44,092,900
%

Profitability & Margins

Gross Margin 49.46%
Operating Margin 19.50%
Net Margin 13.63%
Return on Equity (ROE) 22.02%
Return on Assets (ROA) 6.02%
Asset Turnover 0.44x
Revenue 3-Yr CAGR 12.99%
🛡️

Financial Health & Liquidity

Current Ratio 4.02
Cash Ratio 1.08
Debt / Equity 1.391
Debt / Assets 0.380
Cash & Equivalents $170.18M
Total Debt $619.71M
Book Value / Share $10.10
💧

Cash Flow Efficiency

Operating Cash Flow $156.12M
Capital Expenditures (CapEx) $34.88M
Free Cash Flow $121.23M
OCF / Revenue 21.69%
FCF / Revenue 16.84%
FCF 3-Yr CAGR 23.00%
🏷️

Per Share Metrics

EPS (Diluted) $2.03
EPS (Basic) $2.10
Dividends / Share N/A
Book Value / Share $10.10
EPS YoY Growth -33.66%
🏛️

Balance Sheet (FY 2025)

Total Assets $1.63B
Total Liabilities $1.18B
Stockholders' Equity $445.52M
Current Assets $636.02M
Current Liabilities $158.16M